TRIPS Council To Look At IP And The Public Interest, Business Interest 11/02/2019 by William New, Intellectual Property Watch Leave a Comment The World Trade Organization is the prime gathering point for the world’s governments to discuss and negotiate on policies of the day. A decades-long swinging pendulum within the WTO’s committee on trade and intellectual property is IP’s contribution to innovation and economy and its contribution to the public interest. At its meeting this week, the committee will feature discussions on both.
US Industry IP Index Released: US Advances, India Shows Leadership, EU, Singapore Near Top 08/02/2019 by David Branigan, Intellectual Property Watch 1 Comment The leading United States industry association yesterday released its annual International Intellectual Property Index, ranking countries on their progress in protecting US intellectual property rights. The ranks show the US advancing in the area of patent protection, while retaining the top overall score; India strengthening IP and charting a course for other developing countries; and EU countries dominating the higher scoring bracket with Singapore first on patent protection.
IP Still At Heart Of Access To Medicines Discussions At WHO 07/02/2019 by Catherine Saez, Intellectual Property Watch Leave a Comment Intellectual property is often pointed at as hindering access to medicines by resulting in their long-lasting unaffordability, a view which is strongly opposed by IP proponents. The discussions on access to medicines last week during the World Health Organization Executive Board meeting yielded a record number of interventions by member states and nongovernmental organisations, reflecting the importance of the issue.
WHO Board Sceptical On Changes To Global Flu Framework, Sends Issue To WHA 04/02/2019 by Catherine Saez, Intellectual Property Watch 3 Comments The World Health Organization Executive Board last week remained uncertain on the way forward on questions of access to influenza viruses as countries are increasingly implementing an international protocol regulating the sharing of genetic resources. The Board requested informal discussions be held in the lead-up to the annual World Health Assembly in May.
WIPO Sheds Light On Artificial Intelligence Patenting Trends In New Report 31/01/2019 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization today released its first report on artificial intelligence showing a sharp rise in patenting activities over the last few years. WIPO Director General Francis Gurry called artificial intelligence a “game changer” during a press briefing yesterday and said WIPO hopes to spark a conversation on the issue among its member states this year. As in most other fields, leading patent offices are the United States and China.
Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues 30/01/2019 by Catherine Saez, Intellectual Property Watch Leave a Comment Shortages, faulty supply chains, unbearable prices, weak health systems – the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly.
WHO Member States Call For Transparency, Access To Innovation On Cancer Drug Pricing 30/01/2019 by David Branigan, Intellectual Property Watch Leave a Comment A substantive discussion took place at the World Health Organization Executive Board meeting yesterday in response to a recently released WHO report on cancer drug pricing. Among the variety of perspectives expressed, many formed consensus in calling for increased transparency of research and development (R&D) costs and equitable access to innovative cancer drugs.
Measuring Outputs Seen As Key To WHO Transformation 29/01/2019 by Catherine Saez, Intellectual Property Watch Leave a Comment Measurable outputs are a key element of the World Health Organization transformation and its “triple billion” target. Last week, WHO Executive Board discussed the Impact Framework, a key measurement system. Board members asked clarifications on indicators and underlined the challenge of data collection in many countries. A consultation with country experts is expected to be held before the May World Health Assembly.
WHO Director Tedros: Innovation, Digital Health A Major Pillar In WHO Transformation 24/01/2019 by William New, Intellectual Property Watch 1 Comment The World Health Organization is significantly upgrading its focus on digital health and innovation as it moves into a new era, renovating literally every aspect of the organisation, the WHO director general told member states today.
India, Ecuador, Peru Bring TRIPS Flexibilities Into WHO Universal Health Coverage Discussions 24/01/2019 by Catherine Saez, Intellectual Property Watch 1 Comment Universal health coverage is a goal shared by all members of the World Health Organization. The ways to achieve that goal might however be based on different strategies. As members are working on a common resolution for the approval of the Executive Board of the organisation, and are contributing draft text, India brought up the intellectual property dimension by suggesting the text includes mention of the use of international trade rules flexibilities to protect public health.
